Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of ki-67 and p53 antigen in relation to histopathologic findings

Cancer

Volumn 77, Issue 5, 1996, Pages 843-849

  Kawamura, Tohru ^a   Goseki, Narihide ^a   Koike, Morio ^b   Takizawa, Touichiro ^b   Endo, Mitsuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Histopathologic characteristics; Immunohistochemistry; Ki 67; P53; Squamous cell carcinoma; Superficial carcinoma of the esophagus

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUSCLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030067296     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960301)77:5<843::AID-CNCR6>3.0.CO;2-F     Document Type: Article

References (34)

1. Japanese Society for Esophageal Disease. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 8th ed. Tokyo: Kanehara, 1992.
2. Endo M, Takeshita K, Yoshida M. How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy 1986;18(Suppl 3):11-8.
3. Sugimachi K, Ohno S, Matsuda H, Mori M, Kuano H. Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus. Ann Surg 1987;11:179-83.
4. Goseki N, Koike M, Takizawa T, Maruyama M, Toshida M, Awane K, et al. A Definition of "Early Esophageal Cancer": Histopathological Comparative Study with So-called "Early Gastric Cancer". Stomach and Intestine (Tokyo) 1887;22: 1429-36.
5. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992;69:1088-93.
6. Watanabe H, Tada T, Iwabuchi M, Ajioka Y, Motoyama T. New definition and macroscopic characteristics of early carcinoma of the esophagus. Stomach and Intestine (Tokyo) 1990;25:1075-86.
7. Yoshida M, Muroi M, Momma K, Sakaki N. Endoscopic evaluation of intraepithelial or mucosal cancer of the esophagus. Stomach and Intestine (Tokyo) 1990;25:1059-66.
8. Mercer WE, Avignolo C, Beserga R. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 1984;4:276-82.
9. Finlay CA, Hinds PW, Levine AJ. The p53 protooncogene can act as a supressor of transformation. Cell 1989;57:1086-93.
10. Levine AJ, Momand J, Finlay CA. The p53 tumor supressor gene. Nature 1991;351:453-6.
11. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawal T, Narura H. Expression of p53 in human esophageal carcinoma: An immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Human Pathol 1992;23:1238-41.
12. Shimaya K, Shiozaki H, Inoue M, Tahara H, Monden T, Shimano T, et al. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1993;422:271-6.
13. Serbia M, Porschen R, Borchard F, Holstmann O, Willers R, Gabbert HE. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 1994; 74:2218-23.
14. Wang DY, Xiang YY, Tanaka M, Li XR, Li JL, Shen Q, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 1994;74:3089-96.
15. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with cell proliferation. Int J Cancer 1983;31:13-20.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody. J Immunol 1984;133:1710-5.
17. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Cancer Res 1991;51:3503-6.
18. Yonemura Y, Ooyama S, Sugiyama K, Ninomiya I, Kamata T, Yamaguchi A, et al. Growth fractions in gastric carcinoma determined with monoclonal antibody Ki-67. Cancer 1990; 65:1130-4.
19. Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
20. Skinner DB, Dowlatshahi KD, DeMeester TR. Potentially curable cancer of the esophagus. Cancer 1982;50:1641-5.
21. Endo M, Yoshino K, Takeshita K, Kawano T. Analysis of 1.125 cases of early esophageal carcinoma in Japan. Diseases of the Esophagus 1991;4:71-6.
22. Bonavia L. Early esophageal cancer; results of a European multicenter survey. Br J Surg 1995;82:98-101.
23. Bogomoletz WV, Molas G, Gayet B, Potet F. Superficial squamous cell carcinoma of the esophagus. A report of 76 cases and review of the literature. Am J Surg Pathol 1989;13:535-46.
24. Rubio CA, Uu F, Zhao HZ. Histological classification of intraepithelial neoplasias and microinvasive squamous carcinoma of the esophagus. Am J Surg Pathol 1989;13:685-90.
25. Ide H, Eguchi A, Nakamura T, Hayashi K, Yoshida K, Hanashi S, et al. Endoscopic mucosectomy of superficial esophageal carcinoma evaluated by surgical results. Stomach and Intestine (Tokyo) 1993;28:133-9.
26. Isobe M, Emmanuel BS, Givol D, Givol D, Oren M, Croce CM. Location of the gene for human p53 tumor antigen to band 17 p13. Nature 1986;320:84-5.
27. Banks L, Matlashewski G, Crawford L. Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986;159:529-34.
28. Iggo R, Gatter K, Bartec J, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
29. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovaric J, et al. Patterns of expression of p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer 1990;46:839-44.
30. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, et al. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 1991;6:1779-84.
31. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992;50:859-62.
32. Hurlimann J, Saraga EP. Expression of p53 protein in gastric carcinomas association with histologic type and prognosis. Am J Surg Pathol 1994;18:1247-53.
33. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF. Gannon JV, et al. p53 mutation in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
34. Lambert R. Endoscopic detection and treatment of early esophageal cancer: a critical analysis. Endoscopy 1995; 27:12-8.